Skip to main content
Fig. 7 | BMC Cancer

Fig. 7

From: Glycosylation-related genes mediated prognostic signature contribute to prognostic prediction and treatment options in ovarian cancer: based on bulk and single‑cell RNA sequencing data

Fig. 7

Development of potential therapeutic agents. (A) Schematic diagram of identifying agents with higher sensitivity for patients in high-risk group. (B) Four CTRP-derived drugs were selected. (C) Three PRISM-derived drugs were selected. (D) Correlation between 16 GRGs and chemotherapeutic drugs (E–H) The differential sensitivity of cisplatin, gemcitabine, paclitaxel and gefitinib in high- and low- risk groups

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us